Search Reports
Categories
Categories

Global Plasma-derived Products Market

Global Plasma-derived Products Market Research Report 2025(Status and Outlook)

Report Code : PHA1283
Published Date : 23 January, 2025 | No of Pages: 161

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports

Report Overview

Plasma-derived products refer to a range of therapeutic products that are derived from human plasma, such as immunoglobulins, albumin, and clotting factors. These products are crucial for treating various medical conditions, including immune deficiencies, neurological disorders, and hemophilia. Plasma-derived products are typically obtained through the fractionation of human plasma collected from blood donations. The manufacturing process involves purifying and isolating specific proteins from the plasma, which are then formulated into therapeutic products. These products play a vital role in modern medicine, providing life-saving treatments for patients around the world.

The market for plasma-derived products has been experiencing steady growth in recent years, driven by several key factors. One of the primary market drivers is the increasing prevalence of chronic and autoimmune diseases, which require long-term treatment with plasma-derived products. Additionally, advancements in medical technology and healthcare infrastructure have improved access to these products, driving demand further. Moreover, the aging population in many countries has led to a higher incidence of conditions that require plasma-derived therapies, contributing to market growth. At the same time, ongoing research and development efforts aimed at expanding the applications of plasma-derived products are expected to create new opportunities in the market.

In addition to these factors, the market for plasma-derived products is influenced by regulatory frameworks governing the collection, processing, and distribution of human plasma. Stringent regulations ensure the safety and quality of plasma-derived products, which is a critical factor driving consumer confidence and market growth. Furthermore, increasing investments in plasma fractionation facilities and expanding distribution networks are helping to meet the growing demand for these products globally. Overall, the market for plasma-derived products is poised for continued expansion, driven by evolving healthcare needs, technological advancements, and regulatory developments.

The global Plasma-derived Products market size was estimated at USD 1.48 million in 2024 and is projected to reach USD 1.48 million by 2033, exhibiting a CAGR of 0 during the forecast period.

This report provides a deep insight into the global Plasma-derived Products market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter\'s five forces analysis, value chain analysis, PEST analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma-derived Products Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma-derived Products market in any manner.
Global Plasma-derived Products Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio

Market Segmentation (by Type)
Albumin
Immune Globulin
Coagulation Factor
Others

Market Segmentation (by Application)
Immunology
Hematology
Others

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Plasma-derived Products Market
• Overview of the regional outlook of the Plasma-derived Products Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma-derived Products Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Plasma-derived Products, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Plasma-derived Products
      1.2 Key Market Segments
            1.2.1 Plasma-derived Products Segment by Type
            1.2.2 Plasma-derived Products Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Plasma-derived Products Market Overview
      2.1 Global Market Overview
            2.1.1 Global Plasma-derived Products Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Plasma-derived Products Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Plasma-derived Products Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Plasma-derived Products Product Life Cycle
      3.3 Global Plasma-derived Products Sales by Manufacturers (2020-2025)
      3.4 Global Plasma-derived Products Revenue Market Share by Manufacturers (2020-2025)
      3.5 Plasma-derived Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Plasma-derived Products Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers Plasma-derived Products Sales Sites, Area Served, Product Type
      3.8 Plasma-derived Products Market Competitive Situation and Trends
            3.8.1 Plasma-derived Products Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Plasma-derived Products Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Plasma-derived Products Industry Chain Analysis
      4.1 Plasma-derived Products Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Plasma-derived Products Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Market Restraints
      5.5 Industry News
            5.5.1 New Product Developments
            5.5.2 Mergers & Acquisitions
            5.5.3 Expansions
            5.5.4 Collaboration/Supply Contracts
      5.6 PEST Analysis
            5.6.1 Industry Policies Analysis
            5.6.2 Economic Environment Analysis
            5.6.3 Social Environment Analysis
            5.6.4 Technological Environment Analysis
      5.7 Global Plasma-derived Products Market Porter's Five Forces Analysis
            5.7.1 Global Trade Frictions
            5.7.2 Global Trade Frictions and Their Impacts to Plasma-derived Products Market
      5.8 ESG Ratings of Leading Companies
  6 Plasma-derived Products Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Plasma-derived Products Sales Market Share by Type (2020-2025)
      6.3 Global Plasma-derived Products Market Size Market Share by Type (2020-2025)
      6.4 Global Plasma-derived Products Price by Type (2020-2025)
  7 Plasma-derived Products Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Plasma-derived Products Market Sales by Application (2020-2025)
      7.3 Global Plasma-derived Products Market Size (M USD) by Application (2020-2025)
      7.4 Global Plasma-derived Products Sales Growth Rate by Application (2020-2025)
  8 Plasma-derived Products Market Sales by Region
      8.1 Global Plasma-derived Products Sales by Region
            8.1.1 Global Plasma-derived Products Sales by Region
            8.1.2 Global Plasma-derived Products Sales Market Share by Region
      8.2 Global Plasma-derived Products Market Size by Region
            8.2.1 Global Plasma-derived Products Market Size by Region
            8.2.2 Global Plasma-derived Products Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Plasma-derived Products Sales by Country
            8.3.2 North America Plasma-derived Products Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Plasma-derived Products Sales by Country
            8.4.2 Europe Plasma-derived Products Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Plasma-derived Products Sales by Region
            8.5.2 Asia Pacific Plasma-derived Products Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Plasma-derived Products Sales by Country
            8.6.2 South America Plasma-derived Products Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Plasma-derived Products Sales by Region
            8.7.2 Middle East and Africa Plasma-derived Products Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Plasma-derived Products Market Production by Region
      9.1 Global Production of Plasma-derived Products by Region(2020-2025)
      9.2 Global Plasma-derived Products Revenue Market Share by Region (2020-2025)
      9.3 Global Plasma-derived Products Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Plasma-derived Products Production
            9.4.1 North America Plasma-derived Products Production Growth Rate (2020-2025)
            9.4.2 North America Plasma-derived Products Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Plasma-derived Products Production
            9.5.1 Europe Plasma-derived Products Production Growth Rate (2020-2025)
            9.5.2 Europe Plasma-derived Products Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Plasma-derived Products Production (2020-2025)
            9.6.1 Japan Plasma-derived Products Production Growth Rate (2020-2025)
            9.6.2 Japan Plasma-derived Products Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Plasma-derived Products Production (2020-2025)
            9.7.1 China Plasma-derived Products Production Growth Rate (2020-2025)
            9.7.2 China Plasma-derived Products Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Takeda
            10.1.1 Takeda Basic Information
            10.1.2 Takeda Plasma-derived Products Product Overview
            10.1.3 Takeda Plasma-derived Products Product Market Performance
            10.1.4 Takeda Business Overview
            10.1.5 Takeda SWOT Analysis
            10.1.6 Takeda Recent Developments
      10.2 CSL
            10.2.1 CSL Basic Information
            10.2.2 CSL Plasma-derived Products Product Overview
            10.2.3 CSL Plasma-derived Products Product Market Performance
            10.2.4 CSL Business Overview
            10.2.5 CSL SWOT Analysis
            10.2.6 CSL Recent Developments
      10.3 Grifols
            10.3.1 Grifols Basic Information
            10.3.2 Grifols Plasma-derived Products Product Overview
            10.3.3 Grifols Plasma-derived Products Product Market Performance
            10.3.4 Grifols Business Overview
            10.3.5 Grifols SWOT Analysis
            10.3.6 Grifols Recent Developments
      10.4 Octapharma
            10.4.1 Octapharma Basic Information
            10.4.2 Octapharma Plasma-derived Products Product Overview
            10.4.3 Octapharma Plasma-derived Products Product Market Performance
            10.4.4 Octapharma Business Overview
            10.4.5 Octapharma Recent Developments
      10.5 Kedrion
            10.5.1 Kedrion Basic Information
            10.5.2 Kedrion Plasma-derived Products Product Overview
            10.5.3 Kedrion Plasma-derived Products Product Market Performance
            10.5.4 Kedrion Business Overview
            10.5.5 Kedrion Recent Developments
      10.6 LFB Group
            10.6.1 LFB Group Basic Information
            10.6.2 LFB Group Plasma-derived Products Product Overview
            10.6.3 LFB Group Plasma-derived Products Product Market Performance
            10.6.4 LFB Group Business Overview
            10.6.5 LFB Group Recent Developments
      10.7 Biotest
            10.7.1 Biotest Basic Information
            10.7.2 Biotest Plasma-derived Products Product Overview
            10.7.3 Biotest Plasma-derived Products Product Market Performance
            10.7.4 Biotest Business Overview
            10.7.5 Biotest Recent Developments
      10.8 BPL
            10.8.1 BPL Basic Information
            10.8.2 BPL Plasma-derived Products Product Overview
            10.8.3 BPL Plasma-derived Products Product Market Performance
            10.8.4 BPL Business Overview
            10.8.5 BPL Recent Developments
      10.9 RAAS
            10.9.1 RAAS Basic Information
            10.9.2 RAAS Plasma-derived Products Product Overview
            10.9.3 RAAS Plasma-derived Products Product Market Performance
            10.9.4 RAAS Business Overview
            10.9.5 RAAS Recent Developments
      10.10 CBPO
            10.10.1 CBPO Basic Information
            10.10.2 CBPO Plasma-derived Products Product Overview
            10.10.3 CBPO Plasma-derived Products Product Market Performance
            10.10.4 CBPO Business Overview
            10.10.5 CBPO Recent Developments
      10.11 Hualan Bio
            10.11.1 Hualan Bio Basic Information
            10.11.2 Hualan Bio Plasma-derived Products Product Overview
            10.11.3 Hualan Bio Plasma-derived Products Product Market Performance
            10.11.4 Hualan Bio Business Overview
            10.11.5 Hualan Bio Recent Developments
  11 Plasma-derived Products Market Forecast by Region
      11.1 Global Plasma-derived Products Market Size Forecast
      11.2 Global Plasma-derived Products Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Plasma-derived Products Market Size Forecast by Country
            11.2.3 Asia Pacific Plasma-derived Products Market Size Forecast by Region
            11.2.4 South America Plasma-derived Products Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Plasma-derived Products by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Plasma-derived Products Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Plasma-derived Products by Type (2026-2033)
            12.1.2 Global Plasma-derived Products Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Plasma-derived Products by Type (2026-2033)
      12.2 Global Plasma-derived Products Market Forecast by Application (2026-2033)
            12.2.1 Global Plasma-derived Products Sales (K MT) Forecast by Application
            12.2.2 Global Plasma-derived Products Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Please select License
Single User Price:$ 2800
Site License Price:$ 3400
Enterprise Price:$ 3400